251 related articles for article (PubMed ID: 11039761)
1. Potential of gene therapy for treating osteogenesis imperfecta.
Niyibizi C; Smith P; Mi Z; Robbins P; Evans C
Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S126-33. PubMed ID: 11039761
[TBL] [Abstract][Full Text] [Related]
2. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo.
Niyibizi C; Smith P; Mi Z; Phillips CL; Robbins P
J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):84-91. PubMed ID: 11500956
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy approaches for osteogenesis imperfecta.
Niyibizi C; Wang S; Mi Z; Robbins PD
Gene Ther; 2004 Feb; 11(4):408-16. PubMed ID: 14724682
[TBL] [Abstract][Full Text] [Related]
4. Approaches for skeletal gene therapy.
Niyibizi C; Wallach CJ; Mi Z; Robbins PD
Crit Rev Eukaryot Gene Expr; 2002; 12(3):163-73. PubMed ID: 12449341
[TBL] [Abstract][Full Text] [Related]
5. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
[TBL] [Abstract][Full Text] [Related]
6. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
Gajko-Galicka A
Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
[TBL] [Abstract][Full Text] [Related]
7. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition.
Basel D; Steiner RD
Genet Med; 2009 Jun; 11(6):375-85. PubMed ID: 19533842
[TBL] [Abstract][Full Text] [Related]
8. Advances in osteogenesis imperfecta.
Cole WG
Clin Orthop Relat Res; 2002 Aug; (401):6-16. PubMed ID: 12151877
[TBL] [Abstract][Full Text] [Related]
9. OIM and related animal models of osteogenesis imperfecta.
Shapiro JR; Mcbride DJ; Fedarko NS
Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365
[TBL] [Abstract][Full Text] [Related]
10. Collagen (I) homotrimer potentiates the osteogenesis imperfecta (oim) mutant allele and reduces survival in male mice.
Lee KJ; Rambault L; Bou-Gharios G; Clegg PD; Akhtar R; Czanner G; van 't Hof R; Canty-Laird EG
Dis Model Mech; 2022 Sep; 15(9):. PubMed ID: 36106514
[TBL] [Abstract][Full Text] [Related]
11. Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts.
Dawson PA; Marini JC
Nucleic Acids Res; 2000 Oct; 28(20):4013-20. PubMed ID: 11024182
[TBL] [Abstract][Full Text] [Related]
12. Allele dependent silencing of collagen type I using small interfering RNAs targeting 3'UTR Indels - a novel therapeutic approach in osteogenesis imperfecta.
Lindahl K; Kindmark A; Laxman N; Åström E; Rubin CJ; Ljunggren Ö
Int J Med Sci; 2013; 10(10):1333-43. PubMed ID: 23983594
[TBL] [Abstract][Full Text] [Related]
13. Osteogenesis imperfecta.
Byers PH; Steiner RD
Annu Rev Med; 1992; 43():269-82. PubMed ID: 1580589
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mouse model of the mild dominant form of osteogenesis imperfecta.
Bonadio J; Saunders TL; Tsai E; Goldstein SA; Morris-Wiman J; Brinkley L; Dolan DF; Altschuler RA; Hawkins JE; Bateman JF
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7145-9. PubMed ID: 2402497
[TBL] [Abstract][Full Text] [Related]
15. Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
Deyle DR; Khan IF; Ren G; Wang PR; Kho J; Schwarze U; Russell DW
Mol Ther; 2012 Jan; 20(1):204-13. PubMed ID: 22031238
[TBL] [Abstract][Full Text] [Related]
16. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects.
Pochampally RR; Horwitz EM; DiGirolamo CM; Stokes DS; Prockop DJ
Gene Ther; 2005 Jul; 12(14):1119-25. PubMed ID: 15815702
[TBL] [Abstract][Full Text] [Related]
17. Allele-specific gene silencing in osteogenesis imperfecta.
Ljunggren Ö; Lindahl K; Rubin CJ; Kindmark A
Endocr Dev; 2011; 21():85-90. PubMed ID: 21865757
[TBL] [Abstract][Full Text] [Related]
18. Osteogenesis imperfecta: prospects for molecular therapeutics.
Forlino A; Marini JC
Mol Genet Metab; 2000; 71(1-2):225-32. PubMed ID: 11001814
[TBL] [Abstract][Full Text] [Related]
19. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging.
Oyama M; Tatlock A; Fukuta S; Kavalkovich K; Nishimura K; Johnstone B; Robbins PD; Evans CH; Niyibizi C
Gene Ther; 1999 Mar; 6(3):321-9. PubMed ID: 10435082
[TBL] [Abstract][Full Text] [Related]
20. Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.
Willing MC; Cohn DH; Byers PH
J Clin Invest; 1990 Jan; 85(1):282-90. PubMed ID: 2295701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
